Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Landos Biopharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −9 vs. Q1 2022
- Shares held
- 22.5M
- −1.44M (−6.0%) vs. Q1 2022
- Total value
- $16.4M
- −$18.9M (−53.6%) vs. Q1 2022
- New holders
- 8
- 7 more added
- Sold out
- 17
- 14 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 418 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 343 | $0 | 0.00% | −145−29.7% | Reduced |
| Credit Suisse AG | 3 | $0 | 0.00% | +3 | New |
| JPMorgan Chase & Co | 1,726 | $1.00K | 0.00% | −290,651−99.4% | Reduced |
| Citigroup Inc | 741 | $1.00K | 0.00% | −2,065−73.6% | Reduced |
| FMR LLC | 1,956 | $1.00K | 0.00% | +573+41.4% | Added |
| Acadian Asset Management LLC | 1,344 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,243 | $1.00K | 0.00% | +1,243 | New |
| Wells Fargo & Company | 4,043 | $3.00K | 0.00% | +3,843+1,921.5% | Added |
| Allworth Financial LP | 5,286 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,660 | $7.00K | 0.00% | +3,686+61.7% | Added |
| Stratos Wealth Partners, LTD. | 10,000 | $7.00K | 0.00% | +10,000 | New |
| Morgan Stanley | 9,649 | $8.00K | 0.00% | +2,389+32.9% | Added |
| Raymond James & Associates | 10,350 | $8.00K | 0.00% | +10,350 | New |
| Northern Trust Corp | 12,219 | $9.00K | 0.00% | −33,477−73.3% | Reduced |
| Susquehanna International Group, LLP | 12,529 | $9.00K | 0.00% | +12,529 | New |
| Jane Street Group, LLC | 20,957 | $15.0K | 0.00% | +20,957 | New |
| Citadel Advisors LLC | 21,119 | $16.0K | 0.00% | +21,119 | New |
| Ergoteles LLC | 22,900 | $17.0K | 0.00% | +22,900 | New |
| State Street Corp | 25,200 | $18.0K | 0.00% | −84,996−77.1% | Reduced |
| Two Sigma Advisers, LP | 33,900 | $25.0K | 0.00% | −8,400−19.9% | Reduced |
| Bank of America Corp | 40,280 | $29.0K | 0.00% | −16,041−28.5% | Reduced |
| Deutsche Bank AG | 41,760 | $30.0K | 0.00% | +39,217+1,542.2% | Added |
| Goldman Sachs Group Inc | 42,800 | $31.0K | 0.00% | +23,263+119.1% | Added |
| Two Sigma Investments, LP | 46,460 | $34.0K | 0.00% | −27,191−36.9% | Reduced |
| Geode Capital Management, LLC | 77,554 | $56.0K | 0.00% | −35,901−31.6% | Reduced |
| Vanguard Group Inc | 127,555 | $93.0K | 0.00% | −31,446−19.8% | Reduced |
| Botty Investors LLC | 127,262 | $93.0K | 0.04% | −1,488−1.2% | Reduced |
| Macquarie Group Ltd | 147,182 | $107.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 149,000 | $108.0K | 0.00% | −10,000−6.3% | Reduced |
| BlackRock Inc. | 314,741 | $229.0K | 0.00% | −205,567−39.5% | Reduced |
| Renaissance Technologies LLC | 388,732 | $283.0K | 0.00% | +48,232+14.2% | Added |
| OUP Management Co., LLC | 1,612,764 | $1.17M | 1.62% | −214,714−11.7% | Reduced |
| RTW Investments, LP | 4,275,722 | $3.11M | 0.08% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 14,869,915 | $10.8M | 0.34% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −283,217−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −158,875−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −93,533−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −60,968−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −33,132−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −16,988−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −16,982−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −11,400−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,349−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −2,324−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −1,959−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −761−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −408−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −802−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −406−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |